Whalerock Point Partners’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-60,000
| Closed | -$16K | – | 149 |
|
|
2019
Q2 | $16K | Buy |
60,000
+9,000
| +18% | +$2.4K | 0.01% | 145 |
|
|
2019
Q1 | $14K | Buy |
51,000
+11,000
| +28% | +$3.02K | 0.01% | 128 |
|
|
2018
Q4 | $8K | Hold |
40,000
| – | – | 0.01% | 94 |
|
|
2018
Q3 | $8K | Buy |
40,000
+10,000
| +33% | +$2K | 0.01% | 116 |
|
|
2018
Q2 | $8K | Hold |
30,000
| – | – | 0.01% | 118 |
|
|
2018
Q1 | $8K | Buy |
30,000
+10,000
| +50% | +$2.67K | ﹤0.01% | 196 |
|
|
2017
Q4 | $5K | Hold |
20,000
| – | – | ﹤0.01% | 191 |
|
|
2017
Q3 | $4K | Buy |
+20,000
| New | +$4K | ﹤0.01% | 166 |
|
|
2017
Q2 | – | Sell |
-20,000
| Closed | -$5K | – | 174 |
|
|
2017
Q1 | $5K | Buy |
+20,000
| New | +$5K | ﹤0.01% | 151 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$8K | – | 159 |
|
|
2016
Q3 | $8K | Buy |
+15,000
| New | +$8K | ﹤0.01% | 142 |
|